Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody

Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.